X0206
3
2015-05-06
0
0001339970
aTYR PHARMA INC
LIFE
0001640560
McKew John C.
C/O ATYR PHARMA, INC.
3545 JOHN HOPKINS COURT, SUITE #250
SAN DIEGO
CA
92121
0
1
0
0
Vice President, Research
Stock Option (right to buy)
17.74
2024-10-24
Common Stock
94955
D
Stock Option (right to buy)
9.15
2025-04-17
Common Stock
18858
D
1/6 of the shares subject to this option shall vest and become exercisable on October 20, 2015, and the remaining shares shall thereafter become exercisable in 60 equal monthly installments. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on April 17, 2015. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Exhibit List
Exhibit 24.1 - Power of Attorney
/s/ Nancy Krueger, as Attorney-in-Fact
2015-05-06